Unknown

Dataset Information

EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity.


ABSTRACT:

SUBMITTER: Berg JL 

PROVIDER: S-EPMC8102185 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature